Wayne Rothbaum
$2.6B
Born
Feb 17, 1968
Age
57
Source of Wealth
Biotech investing
Residence
Delray Beach, Florida
Citizenship
United States
Marital Status
Married
Children
3
Education
Master of Arts, George Washington University; Bachelor of Arts/Science, State University of New York at Binghamton
- Wayne Rothbaum, who founded investment firm Quogue Capital in 2001, became a wildly successful biotech investor, deploying only his own funds.
- In 2012, Rothbaum cofounded and became the largest investor in cancer drug developer Acerta Pharma, whose drug Calquence was approved to treat forms of lymphoma and leukemia.
- In 2016, AstraZeneca paid $4 billion for 55% of Acerta Pharma and agreed to acquire the remainder of Acerta for nearly $2.5 billion paid between 2022 and 2024.
- Rothbaum is executive chair of two cancer drug firms: Kartos Therapeutics, which he cofounded in 2016, and Telios Pharma, cofounded in 2019.
- Rothbaum also led a restructuring of listed biotech firm Iovance Biotherapeutics, where he is a board member and the largest shareholder, with a stake of more than 10%.
- Rothbaum's career was first described in the book "For Blood and Money: Billionaires, Biotech and the Quest for a Blockbuster Drug" published in 2023.
- Rothbaum donated $300 million to SUNY Binghamton--for a sports complex and scholarships--and to Ohio State University to build housing for cancer patients.
| Exchange | Ticker | Company Name | Number Of Shares | Share Price | Currency Code |
|---|